Metraipolis › archive › dc_4b1141e808bd

A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1… — Europe PMC PMID:42375358

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42375358
DOI
10.3389/fimmu.2026.1839684
License (as archived)
solo-consultazione
Archived
2026-10-31T10:48:08.511Z
SHA-256 of the archived text
0e19a3a9b70dfe2e20162ab284f813131f6bd84a79323e871b60aaac79a967ae
Stable URL of this page
https://metraipolis.com/documento/dc_4b1141e808bd

How to cite

A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1… — Europe PMC PMID:42375358 — Europe PMC (en), https://europepmc.org/article/MED/42375358 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4b1141e808bd (Metraipolis archive dc_4b1141e808bd, sha256 0e19a3a9b70dfe2e20162ab284f813131f6bd84a79323e871b60aaac79a967ae)
BibTeX
@misc{dc4b1141e808bd,
  title = {A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1… — Europe PMC PMID:42375358},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42375358},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4b1141e808bd; sha256 0e19a3a9b70dfe2e20162ab284f813131f6bd84a79323e871b60aaac79a967ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42375358. Agents can read the archived copy with the MCP tool read_document.